Rationalisation of Antipsychotic Drug Use in Older People, Using [18F]-Fallypride PET

Trial Profile

Rationalisation of Antipsychotic Drug Use in Older People, Using [18F]-Fallypride PET

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 20 Apr 2017

At a glance

  • Drugs Amisulpride (Primary)
  • Indications Alzheimer's disease; Schizophrenia and disorders with psychotic features
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 18 Apr 2017 Status changed from active, no longer recruiting to discontinued.
    • 18 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to United Kingdom Clinical Research Network record.
    • 15 Jul 2015 Accrual to date is 91% according to United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top